Sickle cell disease (SCD) in adults remains a significant clinical challenge, with limited curative options and high morbidity and mortality. Hematopoietic stem cell transplantation (HSCT) offers a potential cure, yet data on its feasibility and outcomes in ad... ...

请注册登录后继续浏览